Browse > Article
http://dx.doi.org/10.5487/TR.2009.25.2.059

Metabolomics, a New Promising Technology for Toxicological Research  

Kim, Kyu-Bong (National Institute of Toxicological Research, Korea Food and Drug Administration)
Lee, Byung-Mu (Division of Toxicology, School of Pharmacy, Sungkyunkwan University)
Publication Information
Toxicological Research / v.25, no.2, 2009 , pp. 59-69 More about this Journal
Abstract
Metabolomics which deals with the biological metabolite profile produced in the body and its relation to disease state is a relatively recent research area for drug discovery and biological sciences including toxicology and pharmacology. Metabolomics, based on analytical method and multivariate analysis, has been considered a promising technology because of its advantage over other toxicogenomic and toxicoproteomic approaches. The application of metabolomics includes the development of biomarkers associated with the pathogenesis of various diseases, alternative toxicity tests, high-throughput screening (HTS), and risk assessment, allowing the simultaneous acquisition of multiple biochemical parameters in biological samples. The metabolic profile of urine, in particular, often shows changes in response to exposure to xenobiotics or disease-induced stress, because of the biological system's attempt to maintain homeostasis. In this review, we focus on the most recent advances and applications of metabolomics in toxicological research.
Keywords
Metabolomics; Biomarker; Toxicology; High-throughput screening (HTS); Risk assessment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bollard, M.E., Keun, H.C., Beckonert, O., Ebbels, T.M., Antti, H., Nicholls, A.W., Shockcor, J.P., Cantor, G.H., Stevens, G., Lindon, J.C., Holmes, E. and Nicholson, J.K. (2005). Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol., 204, 135-151   DOI   ScienceOn
2 Coen, M., O'Sullivan, M., Bubb, W.A., Kuchel, P.W. and Sorrell, T. (2005). Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin. Infect. Dis., 41, 1582-1590   DOI   ScienceOn
3 Dunn, W.B., Bailey, N.J.C. and Johnson, H.E. (2005). Measuring the metabolome: current analytical technologies. Analyst, 130, 606-625   DOI   ScienceOn
4 Fiehn, O. (2002). Metabolomics--the link between genotypes and phenotypes. Plant Mol. Biol., 48, 155-171   DOI   PUBMED   ScienceOn
5 Goodacre, R. (2005). Making sense of the metabolome using evolutionary computation: seeing the wood with the trees. J. Exp. Bot., 56, 245-254   DOI   PUBMED   ScienceOn
6 Kim, K.B., Kim, S.H., Um, S.Y., Chung, M.W., Oh, J.S., Jung, S.C., Kim, T.S., Moon, H.J., Han, S.Y., Oh, H.Y., Lee, B.M. and Choi, K.H. (2009). Metabolomics approach to risk assessment: methoxyclor exposure to rats. J. Toxicol. Environ. Health A (in print)
7 Lee, S.H., Woo, H.M., Jung, B.H., Lee, J., Kwon, O.S., Pyo, H.S., Choi, M.H. and Chung, B.C. (2007). Metabolomic approach to evaluate the toxicological effects of nonylphenol with rat urine. Anal. Chem., 79, 6102-6110   DOI   ScienceOn
8 Lenz, E.M., Bright, J., Knight, R., Westwood, F.R., Davies, D., Major, H. and Wilson, I.D. 2005. Metabonomics with 1HNMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 10, 173-187   DOI   ScienceOn
9 Leo, G.C., Caldwell, G.W., Crooke, J., Malatynska, E., Cotto, C., Hastings, B., Scowcroft, J., Hall, J., Browne, K. and Hageman, W. (2005). The application of nuclear magnetic resonance-based metabonomics to the dominant-submissive rat behavioral model. Anal. Biochem., 339, 174-178   DOI   ScienceOn
10 Lindon, J.C., Holmes, E., Bollard, M.E., Stanley, E.G. and Nicholson, J.K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 9, 1-31   DOI   ScienceOn
11 Nicholson, J.K., Timbrell, J.A. and Sadler, P.J. (1985). Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. Mol. Pharmacol., 27, 644-651   PUBMED
12 Nordstrom, A., Want, E., Northen, T., Lehtio, J. and Siuzdak, G. (2008). Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Anal. Chem., 80, 421-429   DOI   ScienceOn
13 Pitt, J.J., Eggington, M. and Kahler, S.G. (2002). Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin. Chem., 48, 1970-1980   PUBMED
14 Quinones, M.P. and Kaddurah-Daouk, R. (2009). Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol. Dis. (Epub ahead of print) doi:10.1016/j.nbd.2009.02.019   DOI   ScienceOn
15 Rampitsch, C. and Bykova, N.V. (2009). Methods for functional proteomic analyses. Methods Mol. Biol., 513, 93-110   DOI   PUBMED   ScienceOn
16 Tiziani, S., Lopes, V. and Gunther, U.L. (2009). Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia, 11, 269-276   DOI   PUBMED
17 Wang, C., Yang, J. and Nie, J. (2009). Plasma phospholipid metabolic profiling and biomarkers of rats following radiation exposure based on liquid chromatography-mass spectrometry technique. Biomed. Chromatogr. (Epub ahead of print) 10.1002/bmc.1226   DOI
18 Yang, J., Xu, G., Hong, Q., Liebich, H.M., Lutz, K., Schmulling, R.M. and Wahl, H.G. (2004). Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci., 813, 53-58   DOI   PUBMED   ScienceOn
19 van Doorn, M., Vogels, J., Tas, A., van Hoogdalem, E.J., Burggraaf, J., Cohen, A. and van der Greef, J. (2007). Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br. J. Clin. Pharmacol., 63, 562-574   DOI   ScienceOn
20 Weckwerth, W. and Morgenthal, K. (2005). Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today, 10, 1551-1558   DOI   ScienceOn
21 Um, S.Y., Chung, M.W., Kim, K.B., Kim, S.H., Oh, J.S., Oh, H.Y., Lee, H.J. and Choi, K.H. (2009). Pattern recognition analysis for the prediction of adverse effects by NSAIDs using 1H-NMR based metabolomics in rats. Anal. Chem. (in print)
22 Reo, N.V. (2002). NMR-based metabolomics. Drug Chem. Toxicol., 25, 375-382   DOI   PUBMED   ScienceOn
23 Lenz, E.M., Bright, J., Knight, R., Westwood, F.R., Davies, D., Major, H. and Wilson, I.D. 2005. Metabonomics with 1HNMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 10, 173-187   DOI   ScienceOn
24 Lindon, J.C., Nicholson, J.K., Holmes, E., Antti, H., Bollard, M.E., Keun, H., Beckonert, O., Ebbels, T.M., Reily, M.D., Robertson, D., Stevens, G.J., Luke, P., Breau, A.P., Cantor, G.H., Bible, R.H., Niederhauser, U., Senn, H., Schlotterbeck, G., Sidelmann, U.G., Laursen, S.M., Tymiak, A., Car, B.D., Lehman-McKeeman, L., Colet, J.M., Loukaci, A. and Thomas, C. (2003). Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol., 187, 137-146   DOI   ScienceOn
25 Mao, J., Jain, A.K., Center, I.B.M.A.R. and San Jose, C. (1995). Artificial neural networks for feature extraction and multivariatedata projection. IEEE Trans. Neural Networks, 6, 296-317   DOI   ScienceOn
26 Papassotiropoulos, A., Wollmer, M.A., Tsolaki, M., Brunner, F., Molyva, D., Lutjohann, D., Nitsch, R.M. and Hock, C. (2005). A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J. Clin. Psychiatry, 66, 940-947   DOI   ScienceOn
27 Testa, B. and Kramer, S.D. 2006. The biochemistry of drug metabolism--an introduction: part 1. Principles and overview. Chem. Biodivers, 3, 1053-1101   DOI   ScienceOn
28 Bundy, J.G., Willey, T.L., Castell, R.S., Ellar, D.J. and Brindle, K.M. (2005). Discrimination of pathogenic clinical isolates and laboratory strains of Bacillus cereus by NMR-based metabolomic profiling. FEMS Microbiol. Lett., 242, 127-136   DOI   ScienceOn
29 Gieger, C., Geistlinger, L., Altmaier, E., Hrabe de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.W., Wichmann, H.E., Weinberger, K.M., Adamski, J., Illig, T. and Suhre, K. (2008). Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet., 4, e1000282   DOI   PUBMED   ScienceOn
30 Yang, Y., Adelstein, S.J. and Kassis, A.I. (2009). Target discovery from data mining approaches. Drug Discov. Today, 14, 147-154   DOI   ScienceOn
31 Bathen, T.F., Engan, T., Krane, J. and Axelson, D. (2000). Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer Res., 20, 2393-2408   PUBMED
32 Holmes, E., Nicholls, A.W., Lindon, J.C., Ramos, S., Spraul, M., Neidig, P., Connor, S.C., Connelly, J., Damment, S.J., Haselden, J. and Nicholson, J.K. (1998). Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed., 11, 235-244   DOI   ScienceOn
33 Kenney, B. and Shockcor, J.P. (2003). Complementary NMR and LC-MS technologies for metabonomic studies. PharmaGenomics, 56-63
34 Waters, N.J., Holmes, E., Williams, A., Waterfield, C.J., Farrant, R.D. and Nicholson, J.K. (2001). NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol., 14, 1401-1412   DOI   ScienceOn
35 Hrmova, M. and Fincher, G.B. (2009). Functional genomics and structural biology in the definition of gene function. Methods Mol. Biol., 513, 199-227   DOI   PUBMED   ScienceOn
36 Dunn, W.B. and Ellis, D.I. (2005). Metabolomics: current analytical platforms and methodologies. Trac-trends In Analytical Chemistry, 24, 285-294   DOI   ScienceOn
37 Lee, S.H., Yang, Y.J., Kim, K.M. and Chung, B.C. (2003). Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer. Cancer Lett., 201, 121-131   DOI   ScienceOn
38 Lenz, E.M., Bright, J., Wilson, I.D., Hughes, A., Morrisson, J., Lindberg, H. and Lockton, A. (2004). Metabonomics, dietary influences and cultural differences: a 1H NMRbased study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal., 36, 841-849   DOI   ScienceOn
39 Wilson, I.D., Plumb, R., Granger, J., Major, H., Williams, R. and Lenz, E.M. (2005). HPLC-MS-based methods for the study of metabonomics. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 817, 67-76   DOI   ScienceOn
40 Zhu, J., Wiener, M.C., Zhang, C., Fridman, A., Minch, E., Lum, P.Y., Sachs, J.R. and Schadt, E.E. (2007). Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations. PLoS Comput. Biol., 3, e69   DOI   PUBMED   ScienceOn
41 Bino, R.J., Hall, R.D., Fiehn, O., Kopka, J., Saito, K., Draper, J., Nikolau, B.J., Mendes, P., Roessner-Tunali, U., Beale, M.H., Trethewey, R.N., Lange, B.M., Wurtele, E.S. and Sumner, L.W. (2004). Potential of metabolomics as a functional genomics tool. Trends Plant Sci., 9, 418-425   DOI   ScienceOn
42 Brindle, J.T., Antti, H., Holmes, E., Tranter, G., Nicholson, J.K., Bethell, H.W., Clarke, S., Schofield, P.M., McKilligin, E., Mosedale, D.E. and Grainger, D.J. (2002). Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med., 8, 1439-1444   DOI   ScienceOn
43 Clayton, T.A., Lindon, J.C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.P., Le Net, J.L., Baker, D., Walley, R.J., Everett, J.R. and Nicholson, J.K. (2006). Pharmacometabonomic phenotyping and personalized drug treatment. Nature, 440, 1073-1077   DOI   PUBMED   ScienceOn
44 Constantinou, M.A., Theocharis, S.E. and Mikros, E. (2007). Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Toxicol. Appl. Pharmacol., 218, 11-19   DOI   ScienceOn
45 Wei, L., Liao, P., Wu, H., Li, X., Pei, F., Li, W. and Wu, Y. (2009). Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy. Toxicol. Appl. Pharmacol., 234, 314-325   DOI   ScienceOn
46 Fiehn, O., Kopka, J., Dormann, P., Altmann, T., Trethewey, R. N. and Willmitzer, L. (2000). Metabolite profiling for plant functional genomics. Nat. Biotechnol., 18, 1157-1161   DOI   ScienceOn
47 Park, J.C., Hong, Y.S., Kim, Y.J., Yang, J.Y., Kim, E.Y., Kwack, S.J., Ryu do, H., Hwang, G.S. and Lee, B.M. (2009). A metabonomic study on the biochemical effects of doxorubicin in rats using (1)H-NMR spectroscopy. J. Toxicol. Environ. Health A, 72, 374-384   DOI   ScienceOn
48 Schoonen, W.G., Kloks, C.P., Ploemen, J.P., Horbach, G.J., Smit, M.J., Zandberg, P., Mellema, J.R., Zuylen, C.T., Tas, A.C., van Nesselrooij, J.H. and Vogels, J.T. (2007). Sensitivity of (1)H NMR analysis of rat urine in relation to toxicometabonomics. Part I: dose-dependent toxic effects of bromobenzene and paracetamol. Toxicol. Sci., 98, 271-285   DOI   ScienceOn
49 Roessner, U., Willmitzer, L. and Fernie, A.R. (2001). High-resolution metabolic phenotyping of genetically and environmentally diverse potato tuber systems. Identification of phenocopies. Plant Physiol., 127, 749-764   DOI   ScienceOn
50 Stylianou, I.M., Affourtit, J.P., Shockley, K.R., Wilpan, R.Y., Abdi, F.A., Bhardwaj, S., Rollins, J., Churchill, G.A. and Paigen, B. (2008). Applying gene expression, proteomics and single-nucleotide polymorphism analysis for complex trait gene identification. Genetics, 178, 1795-1805   DOI   ScienceOn
51 Kell, D.B. (2004). Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol., 7, 296-307   DOI   PUBMED   ScienceOn
52 Celia, M.H. (2002). The "metabonome" provides real-world information about drug toxicity, gene function. Chem. Eng. News, 80, 66-70
53 Exarchou, V., Krucker, M., van Beek, T.A., Vervoort, J., Gerothanassis, I.P. and Albert, K. (2005). LC-NMR coupling technology: recent advancements and applications in natural products analysis. Magn. Reson. Chem., 43, 681-687   DOI   ScienceOn
54 Hopfield, J.J. (1982). Neural networks and physical systems with emergent collective computational abilities. Proc. Natl. Acad. Sci. U.S.A., 79, 2554-2558   DOI   ScienceOn
55 Nicholson, J.K. and Wilson, I.D. (1989). High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. NMR Spectrosc., 21, 449-501   DOI   ScienceOn
56 Brown, S.C., Kruppa, G. and Dasseux, J.L. (2005). Metabolomics applications of FT-ICR mass spectrometry. Mass Spectrom. Rev., 24, 223-231   DOI   ScienceOn
57 Ebbels, T.M., Keun, H.C., Beckonert, O.P., Bollard, M.E., Lindon, J.C., Holmes, E. and Nicholson, J.K. (2007). Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome Res., 6, 4407-4422   DOI   ScienceOn
58 Gidley, M., Wahlqvist, M., Okada, A., Samman, S. and Sullivan, D. (2004). Naturally functional foods-challenges and opportunities. Proc. Nutri, Soc. Australia, 13, 531
59 Nealson, K.H. and Conrad, P.G. (1999). Life: past, present and future. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 354, 1923-1939   DOI   ScienceOn
60 Yang, J., Xu, G., Zheng, Y., Kong, H., Pang, T., Lv, S. and Yang, Q. (2004). Diagnosis of liver cancer using HPLCbased metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci., 813, 59-65   DOI   PUBMED   ScienceOn
61 Khandelwal, P., Beyer, C.E., Lin, Q., Schechter, L.E. and Bach, A.C., 2nd. (2004). Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approach. Anal. Chem., 76, 4123-4127   DOI   ScienceOn
62 Buchholz, A., Takors, R. and Wandrey, C. (2001). Quantification of intracellular metabolites in Escherichia coli K12 using liquid chromatographic-electrospray ionization tandem mass spectrometric techniques. Anal. Biochem., 295, 129-137   DOI   ScienceOn
63 Allen, J., Davey, H.M., Broadhurst, D., Heald, J.K., Rowland, J.J., Oliver, S.G. and Kell, D.B. (2003). High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol., 21, 692-696   DOI   ScienceOn
64 Denkert, C., Budczies, J., Weichert, W., Wohlgemuth, G., Scholz, M., Kind, T., Niesporek, S., Noske, A., Buckendahl, A., Dietel, M. and Fiehn, O. (2008). Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover. Mol. Cancer., 7, 72   DOI   ScienceOn
65 Price, K.E., Vandaveer, S.S., Lunte, C.E. and Larive, C.K. (2005). Tissue targeted metabonomics: metabolic profiling by microdialysis sampling and microcoil NMR. J. Pharm. Biomed. Anal., 38, 904-909   DOI   ScienceOn
66 Fan, X., Bai, J. and Shen, P. (2005). Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods. Conf. Proc. IEEE Eng. Med. Biol. Soc., 6, 6081-6084   PUBMED
67 Raman, R., Raguram, S., Venkataraman, G., Paulson, J.C. and Sasisekharan, R. (2005). Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat. Methods, 2, 817-824   DOI   ScienceOn
68 Watkins, S.M. and German, J.B. (2002). Metabolomics and biochemical profiling in drug discovery and development. Curr. Opin. Mol. Ther., 4, 224-228   PUBMED
69 Kim, K.B., Chung, M.W., Um, S.Y., Oh, J.S., Kim, S.H., Na, M.A., Oh, H.Y., Cho, W.S. and Choi, K.H. (2008). Metabolomics and biomarker discovery: NMR spectral data of urine and hepatotoxicity by carbon tetrachloride, acetaminophen, and D-galactosamine in rats. Metabolomics, 4, 377-392   DOI   ScienceOn
70 Zhang, J., McCombie, G., Guenat, C. and Knochenmuss, R. (2005). FT-ICR mass spectrometry in the drug discovery process. Drug Discov. Today, 10, 635-642   DOI   ScienceOn
71 Plumb, R.S., Stumpf, C.L., Gorenstein, M.V., Castro-Perez, J.M., Dear, G.J., Anthony, M., Sweatman, B.C., Connor, S.C. and Haselden, J.N. (2002). Metabonomics: the use of electrospray mass spectrometry coupled to reversedphase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun. Mass Spectrom., 16, 1991-1996   DOI   ScienceOn
72 Nicholson, J.K., Lindon, J.C. and Holmes, E. (1999). 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181-1189   DOI   ScienceOn
73 Waters, N.J., Waterfield, C.J., Farrant, R.D., Holmes, E. and Nicholson, J.K. (2006). Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis. J. Proteome Res., 5, 1448-1459   DOI   ScienceOn
74 Wu, L., van Winden, W.A., van Gulik, W.M. and Heijnen, J.J. (2005). Application of metabolome data in functional genomics: a conceptual strategy. Metab. Eng., 7, 302-310   DOI   ScienceOn
75 Craig, A., Sidaway, J., Holmes, E., Orton, T., Jackson, D., Rowlinson, R., Nickson, J., Tonge, R., Wilson, I. and Nicholson, J. (2006). Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J. Proteome Res., 5, 1586-1601   DOI   ScienceOn
76 Holmes, E. and Antti, H. (2002). Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst, 127, 1549-1557   DOI   ScienceOn
77 Raamsdonk, L.M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M.C., Berden, J.A., Brindle, K.M., Kell, D.B., Rowland, J.J., Westerhoff, H.V., van Dam, K. and Oliver, S.G. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol., 19, 45-50   DOI   ScienceOn
78 Choi, M.H., Yoo, Y.S. and Chung, B.C. (2001). Biochemical roles of testosterone and epitestosterone to 5 alpha-reductase as indicators of male-pattern baldness. J. Invest. Dermatol., 116, 57-61   DOI   PUBMED   ScienceOn
79 Beckwith-Hall, B.M., Nicholson, J.K., Nicholls, A.W., Foxall, P.J., Lindon, J.C., Connor, S.C., Abdi, M., Connelly, J. and Holmes, E. (1998). Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol., 11, 260-272   DOI   ScienceOn
80 Griffin, J.L. (2003). Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol., 7, 648-654   DOI   PUBMED   ScienceOn
81 Jonsson, P., Gullberg, J., Nordstrom, A., Kusano, M., Kowalczyk, M., Sjostrom, M. and Moritz, T. (2004). A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal. Chem., 76, 1738-1745   DOI   ScienceOn
82 Saito, K. and Matsuda, F. (2008). Metabolomics for Functional Genomics, Systems Biology, and Biotechnology. Annu. Rev. Plant. Biol. (Epub ahead of print)
83 Ripley, B.D. (1996). Pattern recognition and neural networks. $1^{st}$ Ed. Cambridge university press, UK